EUVIMEDEUVIMED entdecken
Open Access

Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making

Tia T Wheatley

Clinical Journal of Oncology Nursing · 01.06.2026

DOI: 10.1188/26.cjon.187-191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of Oncology Nursing, online erschienen am 02.06.2026. Verfasst von Tia T Wheatley. Beteiligte Einrichtung: Tia T. Wheatley. Hauptthemen laut MEDLINE: Cyclophosphamide, Immunosuppressive Agents, Graft vs Host Disease, Cardiotoxicity. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-transplant cyclophosphamide (PTCy) is a widely used therapy for reducing the risk of graft-versus-host disease in patients undergoing allogeneic stem cell transplantation. PTCy has been associated with early cardiac comp.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideImmunosuppressive AgentsGraft vs Host DiseaseCardiotoxicityHematopoietic Stem Cell TransplantationHumansFemaleMale

Stichwörter der Autor:innen

cardiac toxicitygraft-versus-host diseasepost-transplant cyclophosphamide

Substanzen

CyclophosphamideImmunosuppressive Agents

Autor:innen und Institutionen

  • Tia T. Wheatley.

Zitieren

APA

Wheatley, T. T. (2026). Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/26.cjon.187-191

Vancouver

Wheatley TT. Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making. Clinical Journal of Oncology Nursing. 2026. doi:10.1188/26.cjon.187-191

BibTeX
@article{Wheatley2026,
  author = {Wheatley, Tia T},
  title = {Post-Transplant Cyclophosphamide Cardiac Toxicity: RN–APP Collaborative Assessment and Decision-Making},
  journal = {Clinical Journal of Oncology Nursing},
  year = {2026},
  doi = {10.1188/26.cjon.187-191}
}
Kostenlos starten →